1528-1167/asset/olbannerleft.gif?v=1&s=bae5cfdb8dec65198cd267c78826e3fef2ef0ede)
You have full text access to this OnlineOpen article
High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy
Article first published online: 26 JUN 2009
DOI: 10.1111/j.1528-1167.2009.02183.x
Wiley Periodicals, Inc. © 2009 International League Against Epilepsy
Additional Information
How to Cite
Löscher, W. and Brandt, C. (2010), High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy. Epilepsia, 51: 89–97. doi: 10.1111/j.1528-1167.2009.02183.x
Publication History
- Issue published online: 21 DEC 2009
- Article first published online: 26 JUN 2009
- Accepted April 30, 2009; Early View publication June 26, 2009
References
- , , , , , , , . (2002) Is refractory epilepsy preventable? Epilepsia 43:437–444.
- , . (2008) Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus. Epilepsy Res 82:70–85.
- . (2002) Phenobarbital and other barbiturates: clinical efficacy and use in epilepsy. In LevyRH, MattsonRH, MeldrumBS, PeruccaE (Eds) Antiepileptic drugs. 5th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 514–521.
- , , . (2007) Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy. Epilepsia 48:816–826.
- , , , . (2008) Antiepileptic drug resistant rats differ from drug responsive rats in GABAA-receptor subunit expression in a model of temporal lobe epilepsy. Neurobiol Dis 31:169–187.
- , , , , . (2003) Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats. Epilepsy Res 55:83–103.
- , , . (2004) Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus. Epilepsia 45:1488–1497.
- , , , . (2006) The multidrug transporter hypothesis of drug resistance in epilepsy: proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol Dis 24:202–211.
- , , . (1974) Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology 94:1704–1708.
- , . (1996) Antiepileptic drug therapy: when is epilepsy truly intractable? Epilepsia 37(Suppl 1):S60–S65.
- , , , , . (2002) On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 298:1418–1421.
- . (1999) Patients with refractory seizures. N Engl J Med 340:1565–1570.
- , , . (1994) Sex differences in the anticonvulsant efficacy of phenytoin in amygdala-kindled rats. Brain Res 638:45–52.
- . (1993) Genetic variation in outbred rats and mice and its implications for toxicological screening. J Exp Anim Sci 35:210–220.
- . (2002) Response to early AED therapy and its prognostic implications. Epilepsy Curr 2:69–71. Direct Link:
- . (2007) Refractory epilepsy: clinical overview. Epilepsia 48(Suppl 1):3–7.
- , , , . (2008) Predictors of pharmacoresistant epilepsy: Pharmacoresistant rats differ from pharmacoresponsive rats in behavioral and cognitive abnormalities associated with experimentally induced epilepsy. Epilepsia 49:1759–1767.
- , , , . (2001) Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur J Neurosci 13:657–669.
- , , , , . (2007) Predictors of pharmacoresistant epilepsy. Epilepsy Res 75:192–196.
- , . (2000) Early identification of refractory epilepsy. N Engl J Med 342:314–319.
- , . (2002) Refractory epilepsy: a progressive, intractable but preventable condition? Seizure 11:77–84.
- , . (2004) Drug treatment of epilepsy: when does it fail and how to optimize its use? CNS Spectr 9:110–119.
- , , . (2006) Finding the missing link between ictal bradyarrhythmia, ictal asystole, and sudden unexpected death in epilepsy. Epilepsy Behav 9:19–30.
- , , , , , . (2008) Long-term expressional changes of Na+ -K+ -Cl- co-transporter 1 (NKCC1) and K+ -Cl- co-transporter 2 (KCC2) in CA1 region of hippocampus following lithium-pilocarpine induced status epilepticus (PISE). Brain Res 1221:141–146.
- , . (1989) Comparison of the anticonvulsant efficacy of primidone and phenobarbital during chronic treatment of amygdala-kindled rats. Eur J Pharmacol 162:309–322.
- , . (2005) Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol 76:22–76.
- . (2006) Animal models of drug-refractory epilepsy. In PitkänenA, SchwartzkroinPA, MosheSL (Eds) Models of seizures and epilepsy. Elsevier, San Diego, pp. 551–566.
- . (2007) The pharmacokinetics of antiepileptic drugs in rats:~consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy. Epilepsia 48:1245–1258.
- , , . (2007) Risk factors in sudden death in epilepsy (SUDEP): the quest for mechanisms. Epilepsia 48:859–871.
- . (2002) Phenobarbital and other barbiturates. In LevyRH, MattsonRH, MeldrumBS, PeruccaE (Eds) Antiepileptic drugs. 5th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 489–495.
- , , , , , , . (2007) Disrupted dentate granule cell chloride regulation enhances synaptic excitability during development of temporal lobe epilepsy. J Neurosci 27:14012–14022.
- , , . (2002) P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats. Neurosci Lett 327:173–176.
- . (1972) Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281–294.
- , . (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5:553–564.
- , . (2008) Intrinsic severity as a determinant of antiepileptic drug refractoriness. Epilepsy Curr 8:127–130. Direct Link:
- , , . (1990) Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology 29:845–851.
- , . (2006) The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 47:1423–1440.
- , . (2009) New developments in antiepileptic drug resistance: an integrative view. Epilepsy Curr 9:47–52.
- . (2004) Role of the depolarizing GABA response in epilepsy. Adv Exp Med Biol 548:104–109.
- , , , . (2005) Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia 46(Suppl 11):54–61.
- , , , , , , , . (2007) Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats. J Pharmacol Exp Ther 322:141–147.
- , . (2005) Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain 128:1358–1368.
- , , , , , . (2006) Antiepileptic drug resistant rats differ from drug responsive rats in hippocampal neurodegeneration and GABAA-receptor ligand-binding in a model of temporal lobe epilepsy. Neurobiol Dis 21:633–646.
- , . (1992) Lack of changes in seizure susceptibility during the estrous cycle in kindled rats. Epilepsy Res 13:199–204.